{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T19:03:10Z","timestamp":1782846190816,"version":"3.54.5"},"reference-count":30,"publisher":"JMIR Publications Inc.","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JMIR Form Res"],"abstract":"Abstract<\/jats:title>\n \n Background<\/jats:title>\n Hematuria is one of the most common urologic diseases seen within clinical practice, with a prevalence range of 1.7%\u201031.1%. In 2020, American Urological Association (AUA) guidelines were revised and recommend that following initial evaluation, clinicians should categorize patients into three tiers (low risk, intermediate risk, and high risk) based on various factors. Recent literature has shown that the AUA guidelines have high clinical utility when compared to other international guidelines such as those outlined by the Hematuria Risk Index, Canadian Urological Association, and Kaiser Permanente; however, this guideline remains unvalidated among the population of \u201cwell adults\u201d within the United States.<\/jats:p>\n <\/jats:sec>\n \n Objective<\/jats:title>\n We used a retrospective study design to evaluate data abstracted from the electronic medical records of patients seen in the Emory Healthcare Executive Health Clinic from September 29, 2017, to January 29, 2021, to investigate the utility of risk stratification as a tool for clinical decision-making.<\/jats:p>\n <\/jats:sec>\n \n Methods<\/jats:title>\n According to the AUA risk stratification system, patients were stratified into low-risk and intermediate-risk\/high-risk groups based on sex, age, smoking history, history of gross hematuria, and red blood cells\/high-powered field. The frequencies and percentages of different causes of hematuria across the three risk strata were reported.<\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n Of the 882 instances of red blood cells in urine (URBC) \u22653, a total of 368 (41.72%) underwent a repeat analysis within a 6-month time span, 184 (20.86%) within a 12-month time span, and 330 (37.41%) at >12 months. Instances of a URBC <3 (N=1643) were more likely to have no urologic diagnosis\u20141503 (91.48%) in comparison to 633 (76.27%) for those instances with a URBC >3 (N=830). Ultimately, 23 (100%) participants in the low-risk group had no urologic diagnosis after urinalysis versus 608 (75.62%) in the intermediate-risk\/high-risk group (N=804).<\/jats:p>\n <\/jats:sec>\n \n Conclusions<\/jats:title>\n We found a need for a greater focus on monitoring elevated URBC counts, in accordance with clinical guidelines for managing hematuria in low-risk patients. Future research should examine the impact of risk stratification on clinical decisions and access to care, especially in underserved populations. It should also assess how the new AUA guidelines affect physician referral patterns and explore real-world implementation challenges and facilitators.<\/jats:p>\n <\/jats:sec>","DOI":"10.2196\/75929","type":"journal-article","created":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T16:15:09Z","timestamp":1762445709000},"page":"e75929-e75929","source":"Crossref","is-referenced-by-count":2,"title":["Evaluation of the 2020 American Urological Association Microscopic Hematuria Guidelines in Clinical Practice: Retrospective Chart Review Analysis"],"prefix":"10.2196","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8600-2469","authenticated-orcid":false,"given":"Dominique","family":"Munroe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7151-7184","authenticated-orcid":false,"given":"James","family":"O'Keefe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2841-143X","authenticated-orcid":false,"given":"Danyang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1455-6099","authenticated-orcid":false,"given":"Miranda A","family":"Moore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1010","published-online":{"date-parts":[[2025,12,4]]},"reference":[{"issue":"48","key":"R1","doi-asserted-by":"publisher","first-page":"801","DOI":"10.3238\/arztebl.2018.0801","article-title":"The investigation of hematuria","volume":"115","author":"Bolenz","journal-title":"Dtsch Arztebl Int"},{"issue":"7","key":"R2","doi-asserted-by":"publisher","first-page":"488","DOI":"10.7326\/M15-1496","article-title":"Hematuria as a marker of occult urinary tract cancer: advice for high-value care from the American College of Physicians","volume":"164","author":"Nielsen","journal-title":"Ann Intern Med"},{"issue":"2","key":"R3","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1016\/s0022-5347(17)40763-4","article-title":"The significance of adult hematuria: 1,000 hematuria evaluations including a risk-benefit and cost-effectiveness analysis","volume":"141","author":"Mariani","journal-title":"J Urol"},{"issue":"6 Suppl","key":"R4","doi-asserted-by":"publisher","first-page":"2473","DOI":"10.1016\/j.juro.2012.09.078","article-title":"Diagnosis, evaluation and follow-up of asymptomatic microhematuria (AMH) in adults: AUA guideline","volume":"188","author":"Davis","journal-title":"J Urol"},{"issue":"4","key":"R5","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1097\/JU.0000000000001297","article-title":"Microhematuria: AUA\/SUFU guideline","volume":"204","author":"Barocas","journal-title":"J Urol"},{"issue":"1","key":"R6","doi-asserted-by":"publisher","first-page":"37","DOI":"10.7812\/TPP\/08-083","article-title":"National practice recommendations for hematuria: how to evaluate in the absence of strong evidence?","volume":"13","author":"Loo","journal-title":"Perm J"},{"issue":"12","key":"R7","doi-asserted-by":"publisher","first-page":"2954","DOI":"10.1002\/cncr.25048","article-title":"High-risk patients with hematuria are not evaluated according to guideline recommendations","volume":"116","author":"Elias","journal-title":"Cancer"},{"issue":"10","key":"R8","doi-asserted-by":"publisher","first-page":"1352","DOI":"10.1001\/jamainternmed.2019.2280","article-title":"Comparison of the harms, advantages, and costs associated with alternative guidelines for the evaluation of hematuria","volume":"179","author":"Georgieva","journal-title":"JAMA Intern Med"},{"key":"R9","doi-asserted-by":"publisher","DOI":"10.1097\/AOG.0000000000002059","article-title":"Committee opinion no.703. Asymptomatic microscopic hematuria in women","volume":"129","author":"Nager","journal-title":"Obstet Gynecol"},{"issue":"1","key":"R10","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1097\/JU.0000000000002175","article-title":"Diagnostic and cost implications of the 2020 AUA microhematuria guidelines: modeling impact in a large public health care system","volume":"207","author":"Gold","journal-title":"J Urol"},{"issue":"6","key":"R11","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1001\/jamainternmed.2017.0739","article-title":"Cost-effectiveness of common diagnostic approaches for evaluation of asymptomatic microscopic hematuria","volume":"177","author":"Halpern","journal-title":"JAMA Intern Med"},{"key":"R12","unstructured":"Stata. 2019. URL: https:\/\/www.stata.com [Accessed 24-11-2025]"},{"issue":"3","key":"R13","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1016\/j.urology.2008.01.086","article-title":"Patterns of hematuria referral to urologists: does a gender disparity exist?","volume":"72","author":"Johnson","journal-title":"Urology"},{"issue":"2","key":"R14","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.mayocp.2012.10.004","article-title":"Stratifying risk of urinary tract malignant tumors in patients with asymptomatic microscopic hematuria","volume":"88","author":"Loo","journal-title":"Mayo Clin Proc"},{"issue":"5","key":"R15","doi-asserted-by":"publisher","first-page":"e489","DOI":"10.1016\/j.clgc.2016.04.006","article-title":"Female, Black, and unmarried patients are more likely to present with metastatic bladder urothelial carcinoma","volume":"14","author":"Klaassen","journal-title":"Clin Genitourin Cancer"},{"issue":"4","key":"R16","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1007\/s11606-014-3116-2","article-title":"Gender, race, and variation in the evaluation of microscopic hematuria among Medicare beneficiaries","volume":"30","author":"Bassett","journal-title":"J Gen Intern Med"},{"issue":"4","key":"R17","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1002\/cncr.28416","article-title":"Sex disparities in diagnosis of bladder cancer after initial presentation with hematuria: a nationwide claims-based investigation","volume":"120","author":"Cohn","journal-title":"Cancer"},{"issue":"5","key":"R18","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1016\/j.juro.2017.06.083","article-title":"Variation in the diagnostic evaluation among persons with hematuria: influence of gender, race and risk factors for bladder cancer","volume":"198","author":"Ark","journal-title":"J Urol"},{"key":"R19","unstructured":"Clinical guidelines and standardization of practice to improve outcomes. ACOG. URL: https:\/\/www.acog.org\/clinical\/clinical-guidance\/committee-opinion\/articles\/2019\/10\/clinical-guidelines-and-standardization-of-practice-to-improve-outcomes [Accessed 02-11-2025]"},{"issue":"1","key":"R20","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1186\/s13643-025-02841-z","article-title":"Interventions to improve referrals from primary care to outpatient specialist services for chronic conditions: a systematic review and framework synthesis update","volume":"14","author":"Bolton Saghdaoui","journal-title":"Syst Rev"},{"issue":"3","key":"R21","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1136\/qshc.2008.029918","article-title":"Can guidelines improve referral to elective surgical specialties for adults? A systematic review","volume":"19","author":"Clarke","journal-title":"Quality and Safety in Health Care"},{"issue":"4","key":"R22","doi-asserted-by":"publisher","first-page":"2512","DOI":"10.1177\/1460458220906069","article-title":"Towards standardisation of evidence-based clinical care process specifications","volume":"26","author":"McLachlan","journal-title":"Health Informatics J"},{"key":"R23","doi-asserted-by":"publisher","DOI":"10.1016\/j.urology.2020.03.045","article-title":"Use of a risk stratification tool to guide evaluation of patients with asymptomatic microscopic hematuria","volume":"141","author":"Rabinowitz","journal-title":"Urology"},{"issue":"6","key":"R24","doi-asserted-by":"publisher","first-page":"e168","DOI":"10.1097\/AOG.0000000000002059","article-title":"Committee opinion no.703: asymptomatic microscopic hematuria in women","volume":"129","journal-title":"Obstet Gynecol"},{"issue":"9","key":"R25","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.6009\/jjrt.KJ00001364804","article-title":"Allergies correlated to adverse reactions induced by non-ionic monomeric and ionic dimeric contrast media for contrast enhanced CT examination(scientific paper) [Article in Japanese]","volume":"58","author":"Aoki","journal-title":"J-Stage"},{"issue":"6","key":"R26","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.2214\/ajr.176.6.1761385","article-title":"Trends in adverse events after IV administration of contrast media","volume":"176","author":"Cochran","journal-title":"AJR Am J Roentgenol"},{"issue":"2","key":"R27","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1097\/JU.0000000000002200","article-title":"Defining properly collected urine: thresholds to improve the accuracy of urinalysis for microscopic hematuria evaluation in women","volume":"207","author":"Chen","journal-title":"J Urol"},{"issue":"4","key":"R28","doi-asserted-by":"publisher","first-page":"398","DOI":"10.4997\/JRCPE.2020.409","article-title":"Retrospective studies - utility and caveats","volume":"50","author":"Talari","journal-title":"J R Coll Physicians Edinb"},{"issue":"36","key":"R29","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.15585\/mmwr.mm6936a4","article-title":"Delay or avoidance of medical care because of COVID-19-related concerns - United States, June 2020","volume":"69","author":"Czeisler","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"R30","doi-asserted-by":"publisher","DOI":"10.1016\/j.pmedr.2022.101882","article-title":"Delayed medical care and underlying health in the United States during the COVID-19 pandemic: a cross-sectional study","volume":"28","author":"Gertz","journal-title":"Prev Med Rep"}],"container-title":["JMIR Formative Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/formative.jmir.org\/2025\/1\/e75929","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T18:07:15Z","timestamp":1782842835000},"score":1,"resource":{"primary":{"URL":"https:\/\/formative.jmir.org\/2025\/1\/e75929"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,4]]},"references-count":30,"URL":"https:\/\/doi.org\/10.2196\/75929","relation":{},"ISSN":["2561-326X"],"issn-type":[{"value":"2561-326X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,4]]},"article-number":"v9i48e75929"}}